Royal Marsden Hospital

At the Royal Marsden Hospital, Dr. Angela George is a Consultant Medical Oncologist and Consultant in Oncogenetics. She specializes in the systemic management of gynecological tumors with an emphasis on the therapeutic application of genetic data. She oversees testing for inherited cancer syndromes as the Clinical Director of Genomics at the Royal Marsden and practices oncogenetics. Dr. George received her first training in medical oncology in New Zealand before transferring to the Royal Marsden and continuing her education in oncogenetics at the Institute of Cancer Research, where she received the Chairman's Prize for her thesis on the genetics of ovarian cancer. She oversaw the program's execution, which involves integrating genetic testing into the standard treatment of patients with ovarian, breast, and pancreatic cancer. These programs have now been adopted throughout the UK, and Dr. George has assisted in their establishment throughout the world. They have expanded to include many tumor types and revolutionized the use of standard genetic data. View Profile

Clinical oncologist Dr. Antonia Creak specializes in treating people with tumors of the central nervous system. At The Royal Marsden, she maintains both a private and an NHS practice. Dr. Creak graduated from Imperial College London's Charing Cross and Westminster Medical School in 1995. Dr. Creak began her oncology training in 1999 after finishing her general medical training. The Royal Surrey NHS Foundation Trust, The Royal Marsden NHS Foundation Trust, and Charing Cross Hospital served as its basis of operations. She held the position of Consultant Clinical Oncologist at Brighton and Sussex University Hospitals NHS Trust from June 2011 to 2020. She focused in Neuro-Oncology and Acute Oncology/Cancer with an Unknown Primary. She served as the Clinical Lead for Acute Oncology/Cancer with Unknown Primary beginning in 2014.Clinical oncologist Dr. Antonia Creak specializes in treating people with tumors of the central nervous system. At The Royal Marsden, she maintains both a private and an NHS practice. View Profile

Dr. Atra earned his medical degree from the University of Baghdad in 1977 and moved to the UK in 1987 after completing his study there. At the Hospital for Sick Children, Great Ormond Street, and The Royal Marsden, he received training in pediatric hematology and oncology. Later, in 1997, he was hired as a consultant and appointed director of The Royal Marsden's stem cell program. He is presently employed by The Royal Marsden and St. George's Hospital as a Consultant Paediatric Haematologist/Oncologist. View Profile

Dr. Ethell is a consultant hematologist at The Royal Marsden who specializes in acute leukemia and stem cell transplantation and cares for both pediatric and adult patients. He received his haematology training at North London and Cambridge, where he also became quite interested in stem cell transplantation. He oversees the Royal Marsden's clinical and apheresis services and has served for the past ten years as the Training Programme Director for SW London. View Profile

Consultant clinical oncologist Dr. Merina Ahmed specializes in the treatment of skin, lung, and lymphoma malignancies. At The Royal Marsden, she maintains both a private and an NHS practice. She graduated from Imperial College London's Charing Cross and Westminster Medical School, and she has worked at The Royal Marsden since 2003. Between 2007 and 2009, she conducted head and neck cancer research at The Royal Marsden and The Institute of Cancer Research. Her doctor concentrated on using IMRT and better imaging methods to enhance treatment planning. She was also in charge of the thyroid unit's innovative targeted therapy development. After receiving her MD in 2010, she was hired as a consultant clinical oncologist at The Royal Marsden and St. George's Hospital. She currently treats patients with both early-stage and advanced-stage lung cancer, as well as non-melanoma skin tumors and haematological malignancies (lymphoma, myeloma, and leukemia) using radiation. She has mastered the use of CyberKnife and stereotactic radiation therapy for treating lung cancer, lung metastases, and other oligometastatic disease locations. View Profile

The Head & Neck Unit at The Royal Marsden is home to Professor Paleri, who practices in both the private and public sectors and has the most experience doing transoral robotic surgery in the UK. He is the first surgeon in the UK to undertake robotic free flap reconstructions and has developed a new robotic approach to remove radiorecurrent and radioresidual tumors. Over 200 papers have been published by him, and he has edited many textbooks in the field. He is the primary or joint recipient of £7 million in grant funding. Currently, Professor Paleri holds the positions of president of the British Association of Head and Neck Oncologists, director of the International Centre for Recurrent Head and Neck Cancer, which was supported by The Royal Marsden Cancer Charity, and trustee for the Oracle Cancer Trust, among other national organizations. At the Institute for Cancer Research, he holds the position of Professor of Head and Neck Surgery. View Profile